CG Life is a marketing agency specializing in life science and healthcare, focusing on branding, medical communications, omnichannel marketing, and patient engagement for rare disease brands.

CG Life

CG Life | 7,250 followers on LinkedIn. Your innovation is shaping the next life science breakthrough.
Our science-centered creativity can help tell your story. | We’re a life science marketing and communications agency that understands how science guides your innovations. And science informs how we bring them to market. We harness strategy, creativity, technology, and an analytical mindset to provide a targeted go-to-market plan that respects your science, brand, and audience.

Strategy, Growth, Leadership - as an entrepreneur, I have an insatiable appetite for finding fresh solutions to unmet needs.

David Ormesher

Leader | Coach | Builder of Exceptional Teams

Jon Sawyer

Healthcare Executive - Board Member - Strategic Advisor - U.S. Army Veteran

Fred Walker

Strategic Communications Leader | Precision Medicine + Life Science | Ally

Erik Clausen

ICYMI, November 10 was World Science Day! As science communicators, we help all kinds of audiences—from researchers to clinicians, patients, and the general public—understand complex scientific concepts. So we're launching a new occasional series focusing our science communication on different types of drugs, aka drug modalities. Welcome to Modality Mondays! You may have heard these mentioned, but perhaps want to know more about how some of the lesser-known approaches work to treat various diseases. These newer drug modalities build on the traditional small molecules and biologics, offering unique mechanisms of action. Their existence opens up new frontiers in drug development, particularly for the treatment of complex and rare diseases, cancer, or genetic disorders where traditional small molecules and biologics may not be sufficient. Up first - antisense oligonucleotides (ASOs)! This nifty modality is made of short, synthetic strands of nucleic acids designed to bind to specific RNA sequences. By binding to mRNA, the ASOs can modulate gene expression, typically by blocking protein translation or altering splicing patterns. We love to explain science! #lifescience #lifesciencecommunications #precisionmedicine

From autonomous cars to autologous cell therapies, there was plenty of excitement at Cell & Gene: Meeting on the Mesa. In this blog, we recap some of the hottest conference trends, including renewed focus on patient access and rare diseases. https://lnkd.in/g87SErD7 #cellandgenetherapy #CGMesa24 #lifesciencemarketing #lifesciencecommunications

The highly competitive nature of the biopharma industry makes differentiation absolutely critical. Telling your origin story, cultivating transparency, and ensuring patient engagement are all ingredients for success. Leveraging the right communication strategies can help companies establish and grow differentiation to build value while developing life-changing therapies. Our own Karen Sharma offers key insights on the role of communications on securing long-term growth and success in this fast-paced industry. https://lnkd.in/g8v3tVUc #lifesciencecommunications #healthcarecommunications #biopharma

👟Lace up your sneakers and join us for our first Sweat Equity 5K to kick off the 2025 JPM Healthcare Week! We’re running into the week on a high and healthy note with a knee-friendly fun run through downtown San Francisco. See old friends and make new connections! Join us and our friends from STAT , Gilmartin Group LLC , and MC Services AG on January 13. See you there! Space is limited so register today: https://lnkd.in/gsmkXP9N #JPM2025 #strategiccommunications #healthcarecommunications

Bringing your omnichannel goals to life requires planning and cross-functional collaboration, especially in our world of biopharma. Asking key questions, identifying resources, and measuring efforts should all be part of your plan. Read this overview to refine your 2025 planning with key insights from our own David Ormesher on how to make your omnichannel aspirations a reality. https://lnkd.in/gJAKCSCn #omnichannelstrategy #biopharma #strategy

No matter where your brand is in the development process, appropriate and effective communication is critical. Ensuring that the patient and caregiver perspectives are central to your plans can be a determinant of success. CG Life’s own Bill Berry shares insights developed through decades of interactions with patient and caregiver communities affected by rare diseases. He offers a critical perspective on the development of impactful communications informed by patient experiences and needs. https://lnkd.in/gS52kZ7H #patientcommunications #healthcarecommunications

Wow, what a great week at the Cell and Gene: Meeting on The Mesa hosted by the Alliance for Regenerative Medicine . Cell and gene therapy innovations; issues in patient access, and new opportunities for collaboration. All in the name of improving patient care. Todd Kuna shares a summary of highlights and provides insights about the meeting and what is on the horizon for cell and gene therapy development. #CGMesa24 #cellandgenetherapy #lifesciencemarketing #lifesciencecommunications https://lnkd.in/g87SErD7

The CG Life team is excited and honored to have brought home two #MMMAwards last night! Congratulations to Toolhouse, A CG Life Company and Novo Nordisk for their Gold Award for Branded Website for Healthcare Professionals and Silver Award for Branded Website for Consumers. We're thrilled to celebrate this fantastic partnership that delivers #digital strategy with real world impact. Read what MM+M had to say about the websites here: HCP: https://lnkd.in/g7XXUZGG Consumer: https://lnkd.in/gTiuQi2x #digitalmarketing . #excellence #MMMAwards . #ScienceMarketing . #HealthcareMarketing

Take a listen to CG Life's CEO David Ormesher , on the Life Sciences 360 podcast! David spoke with host Harsh Thakkar , CEO of Qualtivate about the power of storytelling and communicating complex science to the public to resonate with patients, healthcare providers, and investors. David discusses his entrepreneurial journey, how CG Life specializes in biopharmaceutical marketing, and insights into building an agency that combines science and storytelling. He also addresses the strategic importance of focusing on the patient journey and scaling marketing for companies of all sizes. You can also listen to the episode via YouTube: https://lnkd.in/gfwePY8Q #lifesciences #lifesciences360 #podcast

Element CG, a CG Life Company is joining forces with FUJIFILM Cellular Dynamics, Inc to host Culture Club: Where Cells and Celebrations Collide, featuring Promega Corporation ! Be sure to sign up for an evening of scientific and social engagement taking place at the The Rayback Collective in Boulder, CO on Wednesday, October 9th from 4-7pm. https://lnkd.in/g3GnbcJe .

Metric
Company Name	CG Life
Symbol
MSH ID	COM:CGLIFE
Market	PRIVATE
Sector	Commercial & Professional Services
Industry	Marketing & Advertising
Country	US
Stage
Employee Count
Website	cglife.com
LinkedIn	cglife
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CGLI

COM:CGLIFE

CG Life

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue